Leucovorin for autistic disorder

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 18 May 2012: Trial registered, NCT01602016

The trials

NCT01602016: A Folinic Acid Intervention for Autism Spectrum Disorders

State
Stopped early
Phase
Phase 2
People
99 taking part
Started
May 2012
Primary completion
Nov 2015
Arms
Phase III: Open Label Extension of Folinic Acid
Results
Posted on the registry
Papers
doi:10.1038/mp.2016.168
  1. 18 May 2012: Trial registered
  2. 7 Nov 2016: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Also known as Folinoral, Folinic Acid.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.